Chelation Therapy Fails to Improve Outcome in Heart Disease: The TACT2 Trial
In the TACT2 trial, chelation therapy reduced levels of lead in the blood but did not improve cardiovascular outcomes for adults with diabetes and a prior heart attack.
Apr 12th, 2024